The $100 Million Liraglutide Pivot: Why Biocon Is Prioritising US Exports Over The Indian Price War by NDTV Profits | March 17, 2026 4:31 pm | Latest Posts, Market, Trending News While Liraglutide provides immediate momentum, the industry is eyeing 2031, the year Semaglutide patents expire in the US and Europe.
